Britannia Life Sciences Inc. , today announced that it is undertaking a private placement of unsecured debenture units.This non-brokered private placement of subordinated debenture units at a price.
Britannia will undertake a non-brokered private placement of units consisting of subordinated dentures and common shares for aggregate gross proceeds of up to CAD$1,000,000Toronto, Ontario and London
Britannia Life Sciences Inc. is pleased to announce that its subsidiary, Advanced Development & Safety Laboratories , has established a U.S.-based division to assist companies in navigating the.
Britannia Life Sciences Inc: Britannia Life Sciences Appoints Mark Bowes-Cavanagh to Lead Growth of Global Consumer Products Division finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.